Virus non classés : Questions médicales fréquentes
Nom anglais: Viruses, Unclassified
Descriptor UI:D014713
Tree Number:B04.970
Termes MeSH sélectionnés :
Intestinal Neoplasms
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Virus non classés : Questions médicales les plus fréquentes",
"headline": "Virus non classés : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Virus non classés : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-11",
"dateModified": "2025-04-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Virus non classés"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Virus",
"url": "https://questionsmedicales.fr/mesh/D014780",
"about": {
"@type": "MedicalCondition",
"name": "Virus",
"code": {
"@type": "MedicalCode",
"code": "D014780",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Anellovirus",
"alternateName": "Anelloviridae",
"url": "https://questionsmedicales.fr/mesh/D049811",
"about": {
"@type": "MedicalCondition",
"name": "Anellovirus",
"code": {
"@type": "MedicalCode",
"code": "D049811",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.970.270"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nanovirus",
"alternateName": "Nanovirus",
"url": "https://questionsmedicales.fr/mesh/D025682",
"about": {
"@type": "MedicalCondition",
"name": "Nanovirus",
"code": {
"@type": "MedicalCode",
"code": "D025682",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.970.540"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Picobirnavirus",
"alternateName": "Picobirnavirus",
"url": "https://questionsmedicales.fr/mesh/D018708",
"about": {
"@type": "MedicalCondition",
"name": "Picobirnavirus",
"code": {
"@type": "MedicalCode",
"code": "D018708",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.970.610"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Virus non classés",
"alternateName": "Viruses, Unclassified",
"code": {
"@type": "MedicalCode",
"code": "D014713",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Thomas Skovhus Prior",
"url": "https://questionsmedicales.fr/author/Thomas%20Skovhus%20Prior",
"affiliation": {
"@type": "Organization",
"name": "Centre for Rare Lung Diseases, Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark. thbjer@rm.dk."
}
},
{
"@type": "Person",
"name": "Charlotte Hyldgaard",
"url": "https://questionsmedicales.fr/author/Charlotte%20Hyldgaard",
"affiliation": {
"@type": "Organization",
"name": "Diagnostic Center, University Research Clinic for Innovative Patient Pathways, Silkeborg Regional Hospital, Silkeborg, Denmark."
}
},
{
"@type": "Person",
"name": "Claudia Ganter",
"url": "https://questionsmedicales.fr/author/Claudia%20Ganter",
"affiliation": {
"@type": "Organization",
"name": "Centre for Interstitial and Rare Lung Diseases, Pneumology, Thoraxklinik, University of Heidelberg and German Centre for Lung Research, Heidelberg, Germany."
}
},
{
"@type": "Person",
"name": "Elisabeth Bendstrup",
"url": "https://questionsmedicales.fr/author/Elisabeth%20Bendstrup",
"affiliation": {
"@type": "Organization",
"name": "Centre for Rare Lung Diseases, Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark."
}
},
{
"@type": "Person",
"name": "Michael Kreuter",
"url": "https://questionsmedicales.fr/author/Michael%20Kreuter",
"affiliation": {
"@type": "Organization",
"name": "Centre for Interstitial and Rare Lung Diseases, Pneumology, Thoraxklinik, University of Heidelberg and German Centre for Lung Research, Heidelberg, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "COVID-19 in patients with neuroendocrine neoplasms: 2-year results of the INTENSIVE study.",
"datePublished": "2023-04-26",
"url": "https://questionsmedicales.fr/article/36930250",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1530/ERC-22-0395"
}
},
{
"@type": "ScholarlyArticle",
"name": "Long-term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population-based study.",
"datePublished": "2022-07-06",
"url": "https://questionsmedicales.fr/article/35803176",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejca.2022.06.003"
}
},
{
"@type": "ScholarlyArticle",
"name": "Survival of patients with small bowel neuroendocrine neoplasms in Auckland, Aotearoa New Zealand.",
"datePublished": "2022-06-28",
"url": "https://questionsmedicales.fr/article/35762209",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/ans.17851"
}
},
{
"@type": "ScholarlyArticle",
"name": "Bcl-2 and Noxa are potential prognostic indicators for patients with gastroenteropancreatic neuroendocrine neoplasms.",
"datePublished": "2022-07-27",
"url": "https://questionsmedicales.fr/article/35895181",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12020-022-03114-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Progress in the Treatment of Small Intestine Cancer.",
"datePublished": "2023-02-24",
"url": "https://questionsmedicales.fr/article/36826686",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11864-023-01058-3"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Virus",
"item": "https://questionsmedicales.fr/mesh/D014780"
},
{
"@type": "ListItem",
"position": 3,
"name": "Virus non classés",
"item": "https://questionsmedicales.fr/mesh/D014713"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Virus non classés - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Virus non classés",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Virus non classés",
"description": "Comment diagnostiquer un virus non classé ?\nQuels tests sont utilisés pour ces virus ?\nLes virus non classés peuvent-ils être détectés par sérologie ?\nQuels symptômes peuvent indiquer un virus non classé ?\nPeut-on identifier un virus non classé par biopsie ?",
"url": "https://questionsmedicales.fr/mesh/D014713?mesh_terms=Intestinal+Neoplasms&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Virus non classés",
"description": "Quels sont les symptômes courants des virus non classés ?\nLes symptômes varient selon le virus ?\nY a-t-il des symptômes spécifiques à surveiller ?\nLes symptômes peuvent-ils être confondus avec d'autres infections ?\nLes symptômes persistent-ils longtemps ?",
"url": "https://questionsmedicales.fr/mesh/D014713?mesh_terms=Intestinal+Neoplasms&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Virus non classés",
"description": "Comment prévenir les infections par des virus non classés ?\nLes vaccins existent-ils pour ces virus ?\nQuelles mesures d'hygiène sont recommandées ?\nLes masques aident-ils à prévenir la transmission ?\nFaut-il éviter certains aliments pour prévenir ces virus ?",
"url": "https://questionsmedicales.fr/mesh/D014713?mesh_terms=Intestinal+Neoplasms&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Virus non classés",
"description": "Quels traitements sont disponibles pour les virus non classés ?\nLes antiviraux sont-ils efficaces contre ces virus ?\nComment gérer les symptômes d'une infection virale non classée ?\nDes traitements expérimentaux existent-ils ?\nLes antibiotiques sont-ils utiles contre ces virus ?",
"url": "https://questionsmedicales.fr/mesh/D014713?mesh_terms=Intestinal+Neoplasms&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Virus non classés",
"description": "Quelles complications peuvent survenir avec ces virus ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications d'une infection virale ?\nLes complications peuvent-elles être évitées ?\nY a-t-il des risques à long terme associés ?",
"url": "https://questionsmedicales.fr/mesh/D014713?mesh_terms=Intestinal+Neoplasms&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Virus non classés",
"description": "Quels sont les facteurs de risque pour ces virus ?\nLes voyages augmentent-ils le risque d'infection ?\nLe contact avec des animaux est-il un facteur de risque ?\nLes conditions de vie influencent-elles le risque ?\nL'âge joue-t-il un rôle dans le risque d'infection ?",
"url": "https://questionsmedicales.fr/mesh/D014713?mesh_terms=Intestinal+Neoplasms&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un virus non classé ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests PCR, sérologiques et l'analyse des symptômes."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour ces virus ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests PCR et les cultures cellulaires sont couramment utilisés pour l'identification."
}
},
{
"@type": "Question",
"name": "Les virus non classés peuvent-ils être détectés par sérologie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests sérologiques peuvent aider à détecter des anticorps spécifiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un virus non classé ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient, mais incluent souvent fièvre, fatigue et troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Peut-on identifier un virus non classé par biopsie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une biopsie peut être utile, mais elle n'est pas la méthode principale de diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des virus non classés ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, douleurs musculaires, fatigue et troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Les symptômes varient selon le virus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virus non classé peut provoquer des symptômes différents selon son type."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques à surveiller ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveillez les symptômes respiratoires sévères et les signes de déshydratation."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils être confondus avec d'autres infections ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent ressembler à ceux d'autres infections virales courantes."
}
},
{
"@type": "Question",
"name": "Les symptômes persistent-ils longtemps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée des symptômes varie, mais certains peuvent persister plusieurs semaines."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections par des virus non classés ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut l'hygiène, la vaccination si disponible et l'évitement des contacts."
}
},
{
"@type": "Question",
"name": "Les vaccins existent-ils pour ces virus ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Peu de vaccins sont disponibles, car ces virus sont souvent mal compris."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Lavez-vous les mains régulièrement et évitez de toucher votre visage."
}
},
{
"@type": "Question",
"name": "Les masques aident-ils à prévenir la transmission ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les masques peuvent réduire la transmission, surtout dans les zones à risque."
}
},
{
"@type": "Question",
"name": "Faut-il éviter certains aliments pour prévenir ces virus ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les aliments crus ou mal cuits, surtout dans les zones d'épidémie."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les virus non classés ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitements spécifiques; les soins sont généralement symptomatiques."
}
},
{
"@type": "Question",
"name": "Les antiviraux sont-ils efficaces contre ces virus ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antiviraux peuvent être inefficaces, car ces virus ne répondent pas toujours aux traitements standards."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes d'une infection virale non classée ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut le repos, l'hydratation et des médicaments pour soulager la douleur."
}
},
{
"@type": "Question",
"name": "Des traitements expérimentaux existent-ils ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements expérimentaux peuvent être en cours, mais leur efficacité n'est pas prouvée."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils utiles contre ces virus ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces contre les infections virales."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec ces virus ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des pneumonies, des défaillances organiques et des syndromes post-viraux."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications varient selon le virus et l'état de santé du patient."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications d'une infection virale ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion nécessite souvent des soins intensifs et un suivi médical étroit."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être évitées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être évitées par une détection précoce et un traitement approprié."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques à long terme associés ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent développer des syndromes post-viraux persistants."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour ces virus ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'immunodépression, l'âge avancé et les maladies chroniques."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'infection ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones d'épidémie augmente le risque d'exposition."
}
},
{
"@type": "Question",
"name": "Le contact avec des animaux est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains virus non classés peuvent être zoonotiques, se transmettant des animaux à l'homme."
}
},
{
"@type": "Question",
"name": "Les conditions de vie influencent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les conditions de vie surpeuplées ou insalubres augmentent le risque d'infection."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans le risque d'infection ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées et les jeunes enfants sont souvent plus vulnérables."
}
}
]
}
]
}
We conducted a retrospective/prospective worldwide study on patients with neuroendocrine neoplasms (NENs) and a molecularly proven SARS-CoV-2 positivity. Preliminary results regarding 85 patients of t...
Gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) comprise a group of rare malignant tumours with heterogeneous behaviour. This study aimed to assess long-term survival and prognostic facto...
This population-based study included all GEP-NENs diagnosed between 1989 and 2016 in the Netherlands, selected from the Netherlands Cancer Registry. Overall survival (OS) and relative survival (RS) we...
In total, 9697 patients were included. In grade 1, 2 and 3 non-metastatic GEP-NENs (N = 6544), 5-year OS and RS were 81% and 88%, 78% and 83%, and 26% and 30%, respectively. In grade 1 non-metastatic ...
These long-term follow-up data demonstrate significant differences in survival for different grades, tumour stage, and primary origin of GEP-NENs, with the most favourable overall and RS rates in pati...
Small intestinal Neuroendocrine Neoplasms (SI-NENs) are the most common primary malignancy of the small bowel. The aim of this study is to define the survival of patients with an SI-NEN in Auckland, A...
A retrospective study of all patients diagnosed with a jejunal or ileal SI-NEN in the Auckland region between 2000 and 2012 was performed. The New Zealand NETwork! Registry was searched to identify th...
One hundred and seven patients were included in the study. The mean age of patients was 62.8 years (SD 11.9). The 5 and 10-year disease-specific survival for all patients was 66.1% (95% CI 56.5-75.7%)...
This study demonstrates that stage at SI-NEN diagnosis is associated with survival, but resection of the primary or distant metastases in patients with stage IV disease is not. There was no recurrence...
Bcl-2 family proteins are of great significance in the pathogenesis and development of tumors. In this study, the correlations between the expression of Bcl-2 family proteins and clinicopathological f...
105 Patients diagnosed with gastroenteropancreatic NENs (GEP-NENs) with the paraffin specimen of the tumor available were retrospectively included. Immunohistochemistry (IHC) was performed to detect t...
The IHC score of Bcl-2 was significantly higher in neuroendocrine carcinoma (NEC) patients (65.6%), while a higher IHC score of Noxa was more common in neuroendocrine tumor (NET) patients (49.3%). Sur...
Higher expression of Bcl-2 and lower expression of Noxa were associated with unfavorable prognosis of GEP-NENs patients....
Small intestine cancer is rare, accounting for approximately 3% of all gastrointestinal malignancies. The most common histological subtypes include adenocarcinoma, neuroendocrine tumours (NETs) and ga...
To determine the effectiveness and safety of neoadjuvant therapy in gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) and provide evidence-based suggestions for clinical treatment....
The Cochrane Library, Embase, PubMed, and Web of Science were searched for articles published that analyzed the effectiveness and safety of GEP-NEN-targeted neoadjuvant therapy before March 2023. A co...
A total of 417 patients from 13 studies were included in this meta-analysis. The primary variables comprised the objective response rate (ORR), disease control rate (DCR), surgical resection rate, and...
Neoadjuvant therapy is an effective and safe treatment method for GEP-NENs. However, further studies are required to determine the optimal regimen for this therapy in these tumors....
High-grade (grade 3) neuroendocrine neoplasms (G3 NENs) have poor survival outcomes. From a clinical standpoint, G3 NENs are usually grouped regardless of primary site and treated similarly. Little is...
Gastroenteropancreatic NEN (GEP-NEN) are group of malignancies with significant clinical, anatomical and molecular heterogeneity. High-grade GEP-NEN in particular present unique management challenges....
In the current era, multidisciplinary management with access to a combination of functional imaging and targeted molecular profiling can provide important disease characterisation, guide individualise...
Histopathological classifications of neuroendocrine neoplasms (NEN) change regularly and the latest WHO classification published in 2022, which concerns all NEN in the body, attempts to standardize cl...
High-grade gastro-enteropancreatic neuroendocrine neoplasms (GEP-NENs) are a heterogeneous group of rare tumors of two different types: well differentiated neuroendocrine tumors grade 3 (NETs G3) and ...
Seventy-two patients diagnosed with high-grade GEP-NENs who underwent surgery at our institution were recruited for this study. Demographic and clinicopathological characteristics, preoperative serum ...
Serum carcinoembryonic antigen (CEA) was dramatically higher in NECs than in NETs G3 (P = 0.025). After follow-up, 57 of the 72 patients remained for survival analysis. Elevated serum carbohydrate ant...
Serum CEA levels can be used to distinguish NETs G3 from NECs. Preoperative CA19-9, CEA, cancer antigen 125 and SA levels have predictive value in the prognosis of high-grade GEP-NENs. Preoperative CA...